Clinical Trial Update: A Phase 1 Trial to Evaluate CAP256V2LS in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 trial update for CAP256V2LS in healthy adults completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• CAP256V2LS

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV | Phase 1 | Status: COMPLETED | Results posted: 2023-12-18